Abstract
The suppressive action of acyclovir and inosine pranobex was compared in a randomised double blind controlled trial in patients with frequently recurring genital herpes. Fourteen patients received acyclovir and 17 inosine pranobex. Treatment continued for 12 weeks. The time to the first recurrence was significantly longer and the frequency of recurrences significantly less in the recipients of acyclovir. No important side effects were noted. It is concluded that acyclovir is the treatment of choice to suppress often recurring genital herpes.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alder M. W., Mindel A. Genital herpes: hype or hope? Br Med J (Clin Res Ed) 1983 Jun 4;286(6380):1767–1768. doi: 10.1136/bmj.286.6380.1767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang T. W., Weinstein L. Antiviral activity of isoprinosine in vitro and in vivo. Am J Med Sci. 1973 Feb;265(2):143–146. doi: 10.1097/00000441-197302000-00005. [DOI] [PubMed] [Google Scholar]
- Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Furman P. A., St Clair M. H., Fyfe J. A., Rideout J. L., Keller P. M., Elion G. B. Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. J Virol. 1979 Oct;32(1):72–77. doi: 10.1128/jvi.32.1.72-77.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galli M., Lazzarin A., Moroni M., Zanussi C. Inosiplex in recurrent herpes simplex infections. Lancet. 1982 Aug 7;2(8293):331–332. doi: 10.1016/s0140-6736(82)90300-2. [DOI] [PubMed] [Google Scholar]
- Halsos A. M., Salo O. P., Lassus A., Tjøtta E. A., Hovi T., Gabrielsen B. O., Fiddian A. P. Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study. Acta Derm Venereol. 1985;65(1):59–63. [PubMed] [Google Scholar]
- Hayward R. A., Shapiro M. F., Oye R. K. Laboratory testing on cerebrospinal fluid. A reappraisal. Lancet. 1987 Jan 3;1(8523):1–4. doi: 10.1016/s0140-6736(87)90698-2. [DOI] [PubMed] [Google Scholar]
- Kinghorn G. R., Jeavons M., Rowland M., Abeywickreme I., Barton I. G., Potter C. W., Hickmott E. A. Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study. Genitourin Med. 1985 Dec;61(6):387–390. doi: 10.1136/sti.61.6.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mindel A., Coker D. M., Faherty A., Williams P. Recurrent genital herpes: clinical and virological features in men and women. Genitourin Med. 1988 Apr;64(2):103–106. doi: 10.1136/sti.64.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mindel A., Faherty A., Carney O., Patou G., Freris M., Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet. 1988 Apr 23;1(8591):926–928. doi: 10.1016/s0140-6736(88)91725-4. [DOI] [PubMed] [Google Scholar]
- Mindel A., Weller I. V., Faherty A., Sutherland S., Hindley D., Fiddian A. P., Adler M. W. Prophylactic oral acyclovir in recurrent genital herpes. Lancet. 1984 Jul 14;2(8394):57–59. doi: 10.1016/s0140-6736(84)90237-x. [DOI] [PubMed] [Google Scholar]
- Simon L. N., Glasky A. J. Isoprinosine: an overview. Cancer Treat Rep. 1978 Nov;62(11):1963–1969. [PubMed] [Google Scholar]
- Straus S. E., Takiff H. E., Seidlin M., Bachrach S., Lininger L., DiGiovanna J. J., Western K. A., Smith H. A., Lehrman S. N., Creagh-Kirk T. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984 Jun 14;310(24):1545–1550. doi: 10.1056/NEJM198406143102401. [DOI] [PubMed] [Google Scholar]